C

Creadd SA

Updated 6 Aug 2026
Own this investor? Claim the page to unlock editing and verified-owner badge.

Swiss VC firm founded in 2023 investing in pre-growth and growth-stage DeepTech, Biotech/Medtech, and B2B SaaS across Switzerland and Europe.

Funder analysis

Web-researched analysis· 25 Jul 2026· v7

What they fund

Creadd Ventures funds pre-growth and growth-stage companies developing disruptive technologies in DeepTech, Biotech/Medtech, and B2B SaaS [1]. They target ventures with existing worldwide product and market expansion strategies and clear development targets achievable within 3-5 years [1].

Investment thesis

Creadd Ventures converts high-tech into value and transforms innovation into impact by empowering the future of high-tech with real-world value [1]. The firm targets disruptive technologies in DeepTech, AI, Biotech/Medtech, and B2B SaaS, focusing on platform technologies, industrial breakthroughs, and validated technologies with existing worldwide product and market expansion strategies [1]. In healthcare, they revolutionize and digitize the sector by targeting ventures with clear development targets achievable within 3-5 years and potential for significant market impact and high returns [1].

  • DeepTech & AI — Backing platform technologies and industrial breakthroughs that disrupt existing markets and scale globally [1].
  • Healthcare & Medtech — Investing in digitized healthcare ventures with clear 3-5 year development targets and high market impact potential [1].
  • Sustainable Impact — Aligning investments with UN Sustainable Development Goals, including food security, healthcare, clean energy, and sustainable infrastructure [1].
Credibility: The thesis is directly stated on the firm's portfolio page, which outlines their mission to convert high-tech into value and lists their focus areas and impact goals [1].

Value add

Creadd Ventures focuses on converting high-tech into value and transforming innovation into impact [1]. They align investments with UN Sustainable Development Goals, suggesting a focus on sustainable and impactful technologies [1].

Fit verdict: Ideal for founders in DeepTech, Biotech/Medtech, or B2B SaaS seeking growth-stage capital and a focus on sustainable impact.

Founder diligence script:

  • What is your current worldwide product and market expansion strategy?
  • How do you plan to achieve your development targets within the next 3-5 years?
  • How does your technology align with UN Sustainable Development Goals?
  • What is your current valuation and funding requirements for the next round?

Portfolio focus

The portfolio clusters around sustainable development goals, including food security, healthcare, clean energy, and infrastructure [1].

Notable investments & exits

  • Aesyra — A Swiss DeepTech company from EPFL Labs focused on sleep health, founded in 2019 by two young engineers [1].
  • Portfolio Examples — The website lists "Portfolio Companies" and mentions "Examples of Sustainable Development Goals Achieved by our companies" but does not list specific company names beyond Aesyra in the provided text.
  • Exits — Unknown — not covered in the available sources.

Strategic implications

Creadd Ventures' focus on sustainable development goals and high-tech conversion suggests a strategic edge in identifying and scaling technologies with both commercial and societal impact. The firm's emphasis on 3-5 year development targets indicates a preference for ventures with clear, near-term milestones, which may reduce long-term risk but could limit exposure to longer-term, transformative innovations. A key risk is the firm's relatively recent founding (2023), which may limit its track record and ability to attract top-tier co-investors or LPs.

Where they could go further

Creadd Ventures could enhance its value proposition by establishing a more robust network of co-investors and industry experts to support portfolio companies. The firm could benefit from developing a more structured approach to measuring and reporting on the impact of its investments, aligning more closely with emerging ESG standards. Expanding its geographic focus beyond Switzerland and Europe could help Creadd Ventures access a broader pool of high-potential ventures and diversify its portfolio.

Sources

  1. creadd.ch

Co-investors

No co-investors named in this fund's research yet.

Signals & partners focus areas · graph signals · limited partners

Overview

DeepTechBiotechMedtechHealthcareB2B SaaSAI